What Researchers Did
Researchers conducted an updated systematic review to assess the evidence for the effects of adjunctive hyperbaric oxygen therapy (HBOT) in the treatment of acute coronary syndrome (ACS).
What They Found
The provided abstract is truncated and does not present the specific findings or numerical results of the systematic review. The review aimed to determine if adjunctive HBOT reduces the risk of death or major adverse cardiac events in people with ACS.
What This Means for Canadian Patients
Without the complete findings of this systematic review, it is not possible to determine the practical implications of adjunctive hyperbaric oxygen therapy for Canadian patients with acute coronary syndrome. Access to the full review's results would be necessary to assess its relevance to clinical practice in Canada.
Canadian Relevance
This systematic review does not have a stated Canadian connection or involvement.
Study Limitations
The review estimated efficacy from randomized trial comparisons but did not evaluate the likely effectiveness that might be achieved in routine clinical practice.